Abstract
Animal models represent an invaluable tool, which must be judiciously used to provide the greatest benefit to human kind, due to their cost and time effectiveness. The CCN2 null mouse model described in this paper represents a new murine model of craniofacial development. This model is notable for its remarkably consistent phenotype and ease of colony care and propagation. The interaction of CCN2 with the TGF-β, BMP, FGF, EGF, Integrin, and WNT proteins is currently under investigated and signifies a plethora of research opportunities that may help elucidate novel therapeutic options for future patients. This paper presents a descriptive overview of the known craniofacial developmental abnormalities of this model as well as the known molecular signaling aberrances that provide clues to direct future investigative endeavors.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
